← Browse by Condition
Medical Condition

stillbirth

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for stillbirth sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — stillbirth Clinical Trials

How many clinical trials are currently recruiting for stillbirth?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for stillbirth, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for stillbirth?
stillbirth research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a stillbirth clinical trial?
Eligibility criteria for stillbirth trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
University of Manchester 1 trial
Aristotle University Of Thessaloniki 1 trial
Haramaya Unversity 1 trial
NICHD Global Network for Women's and Children's Health 1 trial

Recruiting Clinical Trials

NCT04393259
Recruiting
The Tommy's National Rainbow Clinic Study
Enrollment
500 pts
Location
United Kingdom
Sponsor
University of Manchester
View Trial →
NCT06918236
Recruiting
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
Enrollment
12,084 pts
Location
Bulgaria, Greece, Sp...
Sponsor
Aristotle University Of Thessa...
View Trial →
NCT06273007
Recruiting
Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
Enrollment
500 pts
Location
Ethiopia
Sponsor
Haramaya Unversity
View Trial →
NCT06723392 Phase 3
Recruiting
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Enrollment
1,134 pts
Location
Bangladesh, Democrat...
Sponsor
NICHD Global Network for Women...
View Trial →

Related Conditions

small for gestational age sga (2) fetal growth restriction fgr (1) preeclampsia (1) placenta previa (1) vasa previa (1) obstetric complication (1) maternal death (1) perinatal death (1) perinatal morbidity (1) preterm birth (1) bacteriuria asymptomatic in pregnancy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology